Remus Pharmaceuticals Limited — Others, 25-06-2025: Disclosure under SEBI Takeover Regulations

Remus Pharmaceuticals has confirmed that during the financial year ended March 31, 2025, neither the promoters, promoter group, nor persons acting in concert created any encumbrance or pledge on their shares. As of that date, none of the shares held by the promoter group are encumbered. This clarity on shareholding status reassures investors about the security of promoter-held shares and reflects positively on the company’s ownership stability.